During the past decade, Tokai University Hachioji Hospital conducted 11 clinical trials. In the 10-year time frame, 11 clinical trials started and 4 clinical trials were completed, i.e. on average, 36.4% percent of trials that started reached the finish line to date. In the past 5 years, 6 clinical trials started and 2 clinical trials were completed. i.e. 33.3% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Tokai University Hachioji Hospital" #1 sponsor was "Pfizer" with 6 trials, followed by "Galapagos NV" with 3 trials sponsored, "Janssen Research & Development, LLC" with 3 trials sponsored, "Eli Lilly and Company" with 1 trials sponsored and "Medtronic Cardiac Rhythm and Heart Failure" with 1 trials sponsored. Other sponsors include -4 different institutions and companies that sponsored additional 6 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Tokai University Hachioji Hospital" #1 collaborator was "Gilead Sciences" with 3 trials as a collaborator and "NPO International TRI Network" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 2 trials.

According to Clinical.Site data, the most researched conditions in "Tokai University Hachioji Hospital" are "Ulcerative Colitis" (6 trials), "Crohn's Disease" (3 trials), "Migraine" (2 trials), "Acute Myocardial Infarction" (1 trials) and "Atrial Fibrillation" (1 trials). Many other conditions were trialed in "Tokai University Hachioji Hospital" in a lesser frequency.

Most popular intervention types in "Tokai University Hachioji Hospital" are "Drug" (13 trials), "Biological" (1 trials), "Device" (1 trials), "Other" (1 trials) and "Procedure" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (9 trials), "Filgotinib" (3 trials), "CP-690,550" (2 trials), "Guselkumab" (2 trials) and "Anastrozole" (1 trials). Other intervention names were less common.

The vast majority of trials in "Tokai University Hachioji Hospital" are 15 trials for "All" genders.

Currently, there are NaN active trials in "Tokai University Hachioji Hospital". undefined are not yet recruiting, 6 are recruiting, 2 are Active, not recruiting, and 1 are Enrolling by invitation. In total, there were 4 completed trials in Tokai University Hachioji Hospital, undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in Tokai University Hachioji Hospital, 0 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 11 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 1 trials that are defined as “Not Applicable".